Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Mesoblast ( (MESO) ).
On January 13, 2026, Mesoblast Limited reported to the Australian Securities Exchange that 6,856,460 unquoted options and other convertible securities were exercised or converted into ordinary fully paid shares, with exercises taking place between October 1, 2025 and January 9, 2026. The conversion, which included 1,280,651 options held by key management personnel Eric Rose and a larger number of options issued between 2018 and 2024 to non-KMP holders, increased Mesoblast’s quoted share capital to 1,282,967,187 ordinary shares and left more than 81 million unquoted options outstanding, modestly diluting existing shareholders while signaling ongoing use of equity-based incentives across the company’s leadership and broader employee base.
The most recent analyst rating on (MESO) stock is a Hold with a $21.50 price target. To see the full list of analyst forecasts on Mesoblast stock, see the MESO Stock Forecast page.
Spark’s Take on MESO Stock
According to Spark, TipRanks’ AI Analyst, MESO is a Neutral.
Mesoblast’s overall stock score reflects a company with strong growth potential but significant financial challenges. The earnings call provided positive insights into market access and product launches, which are promising for future growth. However, financial performance and valuation concerns weigh down the score, with technical indicators suggesting caution due to overbought conditions.
To see Spark’s full report on MESO stock, click here.
More about Mesoblast
Mesoblast Limited is an Australia-incorporated company listed on the Australian Securities Exchange under the code MSB. It operates in the biotechnology and biopharmaceutical sector, focusing on developing and commercializing cellular medicines, with its primary securities being ordinary fully paid shares and a range of options and warrants that are actively managed through the ASX capital markets.
Average Trading Volume: 210,659
Technical Sentiment Signal: Strong Buy
Current Market Cap: $2.44B
See more insights into MESO stock on TipRanks’ Stock Analysis page.